ARALEZ PHARMACEUTICALS INC. Depreciation, Amortization and Accretion, Net
ARALEZ PHARMACEUTICALS INC. reported Depreciation, Amortization and Accretion, Net of $1.50 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationAmortizationAndAccretionNet · last filed 2018-03-14
- ARALEZ PHARMACEUTICALS INC. depreciation, amortization and accretion, net for fiscal 2017 was $1.50M, a 275.00% increase from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. depreciation, amortization and accretion, net for fiscal 2016 was $400.00K, a 1900.00% increase from fiscal 2015.
- ARALEZ PHARMACEUTICALS INC. depreciation, amortization and accretion, net for fiscal 2015 was $20.00K, a 0.00% change from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. depreciation, amortization and accretion, net for fiscal 2014 was $20.00K.
| Period end | Depreciation, Amortization and Accretion, Net 12 month |
|---|---|
| 2017-12-31 | $1.50M 10-K · filed 2018-03-14 |
| 2016-12-31 | $400.00K 10-K · filed 2018-03-14 |
| 2015-12-31 | $20.00K 10-K · filed 2017-03-13 |
| 2014-12-31 | $20.00K 10-K · filed 2017-03-13 |